Variational AI Enters $349 Million Collaboration with Merck to Apply Generative AI to Drug Discovery
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
On Sept. 22, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
On Sept. 22, 2025, The Gates Foundation will give $912 million to the Global Fund to Fight AIDS,…
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA) announced it h initiated the approval of…
On Sept. 22, 2025, Celltrion said in a regulatory filing in South Korea its U.S. subsidiary has acquired…
On Sept. 22, 2025, the U.S. Department of Agriculture (USDA) reported that over 400,000 turkeys have been euthanized…
On Sept. 21, 2025, Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) confirmed a new case…
On Sept. 17, 2025, The New England Journal of Medicine published the results from the OASIS 4 phase…
Sept. 15, 2025, a groundbreaking new study led by Prof. Ran Nathan from the Movement Ecology Lab at the Hebrew University…
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
On Sept. 15, 2025, the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) National…
On Sept. 14, 2025, scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University…
On Sept. 12, 2025, scientists from the University of Technology Sydney (UTS) announced they have achieved a major…
On Sept. 4, 2025, a University of Houston lead team announced research showing that a bacterial species found…
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
On Aug. 26, 2025, scientists at Georgia State University (GSU) announced a study published in Scientific Reports that…
On Aug. 10, 2025, computer scientists at ETH Zurich announced they have developed a digital tool capable of…
On Jul. 15, 2025, a new Danish study finds no association between aluminum in childhood vaccines and 50…
On Jul. 7, 2025, Celltrion announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab)…
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
On Jun. 4, 2025, the Conference of State Parties (CoSP) of the African Medicines Agency (AMA) announced the…
On Jun. 3, 2025, a study published in Emerging Infectious Diseases offers encouraging findings for conservationists battling the…
On May 29, 2025, a virus responsible for damaging cotton crops across the southern United States has been…
On May, 26, 2025, researchers in the Department of Biomedical Engineering at Texas A&M University announced they have…
On Mar. 31, 2025, a team of researchers from UC Berkeley and UC San Francisco announced they have…
On Mar. 9, 2025, Celltrion announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO® (omalizumab-igec) as the first and…
On Nov. 11, 2024, a study published in the journal Nature Communications and co-led by UC Davis and…
On Sept. 17, 2024, Boston Scientific announced the close of its acquisition of Silk Road Medical, a medical…
On Sept. 10, 2024, a study, led by the University of Edinburgh, was the first to explore the…
On Sept. 5, 2024, the U.S. Department of Justice announced it had awarded nearly $8 million to cities,…